WEBINAR

Novel Diabetes Medications and Diabetic Retinopathy

OVERVIEW

Join other American Diabetes Association® (ADA) professional members on January 22, 2025 from 11:30 a.m. to 12:30 p.m. EST for a live, one-hour webinar, Novel Diabetes Medications and Diabetic Retinopathy. In this webinar, we will will focus on GLP1 and ophthalmic risk.

LEARNING OBJECTIVES

Discuss novel diabetes medications (GLP1, SGLT2, etc) and diabetic retinopathy
Recognizing nonarteritic anterior ischemic optic neuropathy in people with diabetes

SPEAKER

Andrew J. Barkmeier, M.D.
Mayo Clinic

MODERATORS

Blake Cooper, MD, MPH
Retina Associates

Risa Wolf, MD
John Hopkins University School of Medicine

Note: You do not need to be an ADA professional member to access our free continuing education programs. Simply create a free account and start exploring 70+ free CE courses. Login to get started!